June 20, 2016 / 12:37 PM / a year ago

BRIEF-Revive announces completion of rights offering

June 20 (Reuters) - Revive Therapeutics Ltd :

* Revive announces completion of rights offering for gross proceeds of $844,693 to fund the clinical development of Bucillamine for the treatment of Cystinuria Source text for Eikon: Further company coverage:

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below